Donnez Jacques
Catholic University of Louvain, Société de recherche pour l'infertilité (SRI), Brussels, Belgium.
Fertil Steril. 2017 Dec;108(6):869-871. doi: 10.1016/j.fertnstert.2017.10.015.
Deep endometriosis remains a source of controversy. A number of theories may explain its pathogenesis and many arguments support the hypothesis that genetic or epigenetic changes are a prerequisite for development of lesions into deep endometriosis. Deep endometriosis is frequently responsible for pelvic pain, dysmenorrhea, and/or deep dyspareunia, but can also cause obstetrical complications. Diagnosis may be improved by high-quality imaging. Therapeutic approaches are a source of contention as well. In this issue's Views and Reviews, medical and surgical strategies are discussed, and it is emphasized that treatment should be designed according to a patient's symptoms and individual needs. It is also vital that referral centers have the knowledge and experience to treat deep endometriosis medically and/or surgically. The debate must continue because emerging trends in therapy need to be followed and investigated for optimal management.
深部子宫内膜异位症仍然是一个有争议的问题。一些理论可以解释其发病机制,许多观点支持这样的假说,即基因或表观遗传变化是病变发展为深部子宫内膜异位症的先决条件。深部子宫内膜异位症常导致盆腔疼痛、痛经和/或深部性交困难,但也可引起产科并发症。高质量的影像学检查可能有助于诊断。治疗方法也是一个争论的焦点。在本期的观点与评论中,讨论了药物和手术策略,并强调应根据患者的症状和个体需求制定治疗方案。转诊中心具备药物和/或手术治疗深部子宫内膜异位症的知识和经验也至关重要。由于需要跟踪和研究治疗的新趋势以实现最佳管理,这场争论必须继续下去。